Hyperhomocysteinemia Clinical Trials
Conditions / Hyperhomocysteinemia
Delta Trials records 18 clinical trials for Hyperhomocysteinemia in its publicly accessible dataset. From the full dataset, 1 actively seeking eligible participants and 15 trials have reached completion. This research is conducted across 17 study locations around the world. An additional 2 trials are active but not currently open for enrollment. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, with history tracked across multiple versions.
Trial Status
18
Total Trials
1
Recruiting
15
Completed
2
Other Active
0
Terminated since 2020
17
Study Locations
Browse by location (17 total)
- Novosibirsk, Russia 2 trialsAll trials in Novosibirsk, Russia
- Dallas, United States 1 trialAll trials in Dallas, United States
- Belgrade, Serbia 1 trialAll trials in Belgrade, Serbia
- Guangzhou, China 1 trialAll trials in Guangzhou, China
- Singapore, Singapore 1 trialAll trials in Singapore, Singapore
- Bangkok, Thailand 1 trialAll trials in Bangkok, Thailand
- Bangkok, Thailand 1 trialAll trials in Bangkok, Thailand
- Yatou, China 1 trialAll trials in Yatou, China
- Esslingen Am Neckar, Germany 1 trialAll trials in Esslingen Am Neckar, Germany
- Bologna, Italy 1 trialAll trials in Bologna, Italy
- All trials in Yuanshi County of Shijiazhuang, China
- Pune, India 1 trialAll trials in Pune, India
- Londrina, Brazil 1 trialAll trials in Londrina, Brazil
- Banjul, The Gambia 1 trialAll trials in Banjul, The Gambia
- Monterrey, Mexico 1 trialAll trials in Monterrey, Mexico
- Asyut, Egypt 1 trialAll trials in Asyut, Egypt
- Rio de Janeiro, Brazil 1 trialAll trials in Rio de Janeiro, Brazil
- Washington D.c, United States 1 trialAll trials in Washington D.c, United States
- Washington D.c., United States 1 trialAll trials in Washington D.c., United States